A service of StreetInsider.com
Ticker Symbol
Welcome

Most Popular

AAPL 442.14
GOOG 882.79
MSFT 34.15
BAC 13.21
FB 25.06

Recently Added

ADXS 0.04
PSON 1.03
JRJC 1.62
LYG 3.70
NBG 1.22

Gaining Speed

RSO 6.46
PSON 1.03
LYG 3.70
CANV 11.11
ADXS 0.04
1.81 +0.00 (0.00%) CORT

Click Here to Receive Instant E-mail and RSS Alerts


Trade CORT now with

Stock Details

Last Trade:1.81 Change:+0.00 (0.00%) Prev Close:1.81 Open: 1.78 Days Range:1.68 – 1.82 52 Week Range: 1.27 - 4.55 Volume:6298977 P/E: N/A
EPS:-0.40

Member Comments

No member comments available for CORT


Not logged in - Log in or Sign up to leave comments





View AllRecent Alerts 05/24/13

Recent Alert on 05/06/13 at 7:27am
Piper Jaffray Downgrades Corcept Therapeutics (CORT) to Neutral

Piper Jaffray downgraded Corcept Therapeutics (NASDAQ: CORT) from Overweight to Neutral with a price target of $2.00 (from $4.00). For an analyst ratings summary and ratings history on Corcept Therapeutics click here. For more ratings news on... Read More

Recent Alert on 05/02/13 at 4:27pm
Corcept Therapeutics, Inc. (CORT) Posts Q1 loss of 10c/Share
Recent Alert on 03/07/13 at 5:05pm
Corcept Therapeutics, Inc. (CORT) Reports In-Line Q4 Loss of 9c/Share

View AllRecent Press Releases

No Recent Press Releases Available

View AllRecent SEC Filings

SEC Filing on 05/21/13 at 4:13pm
Form 8-K CORCEPT THERAPEUTICS For: May 17
SEC Filing on 05/21/13 at 1:01pm
Form 4 CORCEPT THERAPEUTICS For: May 17 Filed by: BAKER G LEONARD JR
SEC Filing on 05/21/13 at 12:49pm
Form 4 CORCEPT THERAPEUTICS For: May 17 Filed by: ENRIGHT PATRICK G
SEC Filing on 05/20/13 at 4:15pm
Form 4 CORCEPT THERAPEUTICS For: May 17 Filed by: TURNER JOSEPH L
SEC Filing on 05/20/13 at 4:14pm
Form 4 CORCEPT THERAPEUTICS For: May 17 Filed by: MAHONEY DAVID L

View AllRecent Blog Posts

Blog Posts on 04/17/13 at 10:48am
2 High Risk Biotech Stocks Under $2 That Could Yield A High Reward
Blog Posts on 03/01/13 at 9:41am
2 $2 Biotech Stocks Insiders Are Buying
Blog Posts on 02/14/13 at 12:27pm
Corcept Therapeutics' CEO Corporate Revenue Update (Transcript)
Blog Posts on 02/14/13 at 12:27pm
Corcept Therapeutics' CEO Discusses Q4 2012 Results - Earnings Call Transcript
Blog Posts on 01/23/13 at 4:25am
3 Small Cap Movers With Similar Trends But Different Outlooks